Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
14 juin 2021 07h00 HE
|
Enochian Biosciences, Inc.
LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that...
Enochian BioSciences объявляет о научной презентации человека с ВИЧ, демонстрирующего контролируемые уровни вируса в крови в течение 255 дней после лечения с помощью новой клеточной терапии
14 mai 2021 15h19 HE
|
Enochian Bioscience
ЛОС-АНДЖЕЛЕС, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., компания, специализирующаяся на генно-модифицированных клеточных и иммунных методах лечения инфекционных заболеваний и...
Enochian BioSciences annuncia la presentazione scientifica del caso di un soggetto affetto da HIV con livelli controllati di virus nel sangue per 255 giorni in seguito al trattamento con una nuova terapia cellulare
14 mai 2021 15h19 HE
|
Enochian Bioscience
LOS ANGELES, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., un’azienda specializzata in terapie cellulari e immunitarie basate su geni modificati per la cura di malattie infettive e...
Enochian BioSciences veröffentlicht die wissenschaftliche Präsentation zu einer mit HIV infizierten Person, bei der nach der Behandlung mit einer neuartigen Zelltherapie nach 255 Tagen eine niedrige Viruslast im Blut nachgewiesen wurde
14 mai 2021 15h19 HE
|
Enochian Bioscience
LOS ANGELES, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., ein Unternehmen, das sich auf zelluläre und immunologische Therapien mithilfe genetischer Veränderungen bei...
Enochian BioSciences annonce la présentation scientifique d'une personne atteinte du VIH avec des niveaux de virus dans le sang contrôlés pendant 255 jours après un traitement utilisant une nouvelle thérapie cellulaire
14 mai 2021 15h19 HE
|
Enochian Bioscience
LOS ANGELES, 14 mai 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., une société axée sur les thérapies cellulaires et immunitaires génétiquement modifiées pour les maladies infectieuses et le...
Enochian BioSciences kondigt een wetenschappelijke presentatie aan van een persoon met HIV met vertoning van gecontroleerde bloedniveaus van de virus gedurende 255 dagen na de behandeling met een Novel Cellular Therapy
14 mai 2021 15h19 HE
|
Enochian Bioscience
LOS ANGELES, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences Inc., een bedrijf dat zich richt op genetisch gemodificeerde cellulaire en immuuntherapieën bij infectieziekten en kanker, kondigde...
Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy
12 mai 2021 16h29 HE
|
Enochian Biosciences, Inc.
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced the...
Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy
12 mai 2021 08h00 HE
|
Enochian Biosciences, Inc.
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy
24 mars 2021 18h00 HE
|
Enochian Biosciences, Inc.
LOS ANGELES, March 24, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Seraph Research Institute (SRI) and Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in...
Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference
22 févr. 2021 17h15 HE
|
Enochian Biosciences, Inc.
LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will...